Director of Medical Affairs

Region: Americas
Location: Boston MA

Advertising Date: Mon 09 August 2021

Sirtex Medical is a global healthcare business with offices in Boston, Sydney, Germany, and Singapore, working to improve outcomes in people with cancer. Our current lead product is a targeted radiation therapy for liver cancer called SIR-Spheres® Y-90 resin microspheres. More than 100,000 doses have been supplied to treat patients with liver cancer at more than 1,300 medical centers in over 50 countries. We are a fast growing, dynamic organization.

The primary role of the Senior Director/Director of Medical Affairs will be to assist in further establishing and building the medical affairs function for the company from the ground up.

Responsibilities/Authorities

  • Continue to grow the medical affairs function for the company. This will include developing core materials, training new employees, establishing corporate guidelines and all other aspects of building a successful
  • Provide medical expertise to the Commercial Team to assist in the development and execution of compliant commercial
  • Work closely with senior leadership to support commercialization and research activities. This will include: Health Outcomes Research, Medical Information, Publication planning, KOL development, and other related
  • Provide field-based support for Medical Science Liaison
  • Act as a scientific expert between company and the medical community through the dissemination and clarification of scientific data and
  • Provide support for ongoing clinical trials and assist with site recruitment, enrollment and management of company sponsored and investigator-initiated
  • Facilitate involvement in national, regional, and local educational forums including advisory boards, symposia, and CME
  • Serve as an expert consultant to internal cross-functional partners within company by providing product related scientific information and technical support for training.
  • Undergo all formal Training Events as may be Directed from time-to-time
  • Observe and Comply with all Sirtex Corporate Policies
  • Work within, and ensure adherence to Quality System procedures, work instructions and other Quality System
  • Work within, and ensure adherence to Health, Safety and Environment Management System procedures, instructions and other

Educational Prerequisites and Skill Requirements.

  • Strong understanding of clinical research trials, related medical practice, clinical decision-making, healthcare systems, reimbursement, and other aspects impacting patient care
  • Excellent communication skills, using the spoken word, writing clearly and concisely, and presenting information publicly
  • Effectively build relationships with customers and co-workers
  • Prioritize multiple assignments, and deliver results in dynamic work environment
  • Work independently and as part of a diverse team
  • Complete assigned tasks under stressful situations
  • Organize and direct oneself and effectively supervise others
  • Work independently with minimal supervision
  • Able to convince a group of people to work toward a goal
  • Excellent interpersonal skills, gets along well with a variety of personalities and individuals
  • MD, PharmD, PhD or significant clinical oncology experience is preferred
  • 5 plus years of experience in biotech/pharmaceutical industry
  • Minimum of 3-5 years MSL management experience

What you can expect from Sirtex:

If you have the right skills and experience and want to work for a company making a real difference to the quality of people’s lives, Sirtex will offer the right candidate:

  • Diverse and flexible employment and working arrangements to achieve the optimum balance between work and personal responsibilities and objectives.
  • A working culture of respect, diversity, and performance to help facilitate an inclusive culture.
  • Attractive compensation and benefit packages which are practical, robust, fair and equitable.
  • A place to grow through career development and training opportunities.
  • Challenging work to continue to develop new and better ways to improve clinical outcomes for oncology treatment around the world.
  • Physical requirements include sitting, walking, standing for prolonged amount of time, possible exposure to radiation.

HOW TO APPLY:

To apply, please click the apply button or email your cover letter and resume to Human Resources at recruitment@sirtex.com

Sirtex is an Equal Opportunity/Affirmative Action Employer including Disabled/Vets


Now leaving sirtex.com

You are about to leave the Sirtex Web site. This link is provided to you as a service and will take you to a site maintained by a third party who is solely responsible for the content.

Please be aware that Sirtex takes no responsibility for content of these external sites, nor do we endorse, warrant or guarantee the products, services or information described or offered on other internet sites.

Click 'Continue' to proceed to the third-party Web site.

Continue

×

Now leaving sirtex.com

You are about to leave the Sirtex Website. This link is provided to you as a service and will take you to the Sirtex Virtual Booth.

Sirtex is responsible for the content of the Virtual Booth, which is hosted on a website maintained by a third-party. Except for Sirtex’s Virtual Booth experience, please be aware that Sirtex takes no responsibility for the other content of these external sites, nor do we endorse, warrant, or guarantee the products, services or information described or offered on other internet sites.

Continue

×

You are now leaving your current sirtex.com region

The Sirtex site you are linking to is intended only for healthcare practitioners and patients outside your current region. Any products discussed herein may have different approved product labeling; therefore, any information provided may not be appropriate for use in your region.

Click 'Continue' to proceed to the other Sirtex region Web site.

Continue

×

Effective May 7, 2021, SIR-Spheres will have the following indication for use:
SIR-Spheres Y-90 resin microspheres are indicated for the treatment of unresectable hepatocellular carcinoma (HCC) and unresectable metastatic liver tumors from primary colorectal cancer in patients refractory to or intolerant of chemotherapy.

Click here to view our Technical Bulletin.

Ok